PMGC Holdings (ELAB) Interest Coverage Ratio (2022 - 2026)
PMGC Holdings (ELAB) posted Interest Coverage Ratio of 1.19 for Q1 2026, up 88.25% sequentially from 10.15 in Q4 2025, and down 110.24% YoY from 11.63 in Q1 2025.
PMGC Holdings (ELAB) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Interest Coverage Ratio for 5 years, with the latest figure at 1.19 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 110.24% year-over-year to 1.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.86 (up 51.01% YoY) and the FY2025 annual result came in at 6.7, down 1093.28% from the prior year.
- Interest Coverage Ratio rose to 1.19 in Q1 2026 per ELAB's latest filing, from 10.15 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 11.63 in Q1 2025 and troughed at 730.4 in Q3 2022.
- A 5-year average of 170.93 and a median of 9.21 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 46003.09% in 2024, then surged 230.39% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 424.75 in 2022, then sank by 55.27% to 659.51 in 2023, then soared by 100.46% to 3.01 in 2024, then sank by 436.67% to 10.15 in 2025, then surged by 88.25% to 1.19 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.19, 10.15, and 1.93 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 1.42 |
| 10 | PMGC Holdings | 31.70 Mn | 12.90 Mn | 385,691.00 | -6.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 |
| Dec 31, 2025 | -10.15 |
| Sep 30, 2025 | -1.93 |
| Mar 31, 2025 | 11.63 |
| Dec 31, 2024 | 3.01 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -9.50 |
| Mar 31, 2024 | -8.92 |
| Dec 31, 2023 | -659.51 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -238.90 |
| Mar 31, 2023 | -321.09 |
| Dec 31, 2022 | -424.75 |
| Sep 30, 2022 | -730.40 |